ImmunoPrecise Antibodies (IPA)
(Delayed Data from NSDQ)
$1.89 USD
+0.08 (4.42%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.89 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
ImmunoPrecise Antibodies Ltd.'s dividend yield currently sits at 0%, which is in-line with the Medical Info Systems industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
IPA 1.89 +0.08(4.42%)
Will IPA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IPA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IPA
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates
ImmunoPrecise Antibodies (IPA) Upgraded to Buy: What Does It Mean for the Stock?
IPA: What are Zacks experts saying now?
Zacks Private Portfolio Services
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Misses Revenue Estimates
P3 Health Partners Inc. (PIII) Reports Q4 Loss, Lags Revenue Estimates
Nyxoah SA (NYXH) Reports Q4 Loss, Lags Revenue Estimates
Other News for IPA
ImmunoPrecise Antibodies divests Netherlands facilities to AVS Bio
ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate ...
AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and ...
ImmunoPrecise Antibodies Ltd (IPA) Q4 2025 Earnings Call Highlights: Record Revenue and ...
ImmunoPrecise Antibodies Ltd. (IPA) Q4 2025 Earnings Conference Call Transcript